CHIMERIC THERAPEUTICS LIMITED - Charts / Financials

25.0%

0.3¢

Market Cap $6.045M

Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Day
Open	0.4¢		Day High	0.4¢		Day Low	0.3¢
Daily Volume	6311811

Bids		Sellers
Number	Price	Volume		Number	Price	Volume
78	0.3¢	84735861		23	0.4¢	86304338

Directors & Senior Management

Mr. Paul Hopper	Executive Chairman of the Board, Founder
Mr. Phillip Hains	Chief Financial Officer, Joint Company Secretary, Director
Dr. Rebecca Mcqualter	Chief Operating Officer
Dr. Eliot Bourk	Chief Business Officer
Dr. Jason B. Litten	Chief Medical Officer
Mr. Nathan Jong	Joint Company Secretary
Prof. H. Miles Prince	Non-Executive Director
Dr. Lesley Russell	Non-Executive Director
Mr. Eric M. Sullivan	Non-Executive Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.3¢		Change -0.001(25.0%)		Mkt cap ! $6.045M

Open	High	Low	Value	Volume
0.4¢	0.4¢	0.3¢	$22.28K	6.311M

Buyers (Bids)

No.	Vol.	Price($)
78	84735861	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	86304338	23

View Market Depth

No.	Vol.	Price($)
71	80251196	0.003
24	24996485	0.002
12	52464000	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	86304338	23
0.005	33049651	21
0.006	12474007	15
0.007	6512518	7
0.008	7317101	5

Last trade - 14.27pm 25/07/2025 (20 minute delay)

CHM (ASX) Chart

CHIMERIC THERAPEUTICS LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories